Remove Development Remove Medicine Remove Protein Remove Research Analyst
article thumbnail

Outsourcing Peptide Synthesis: Preferred Choice of Drug Developers

Roots Analysis

Owing to the challenges involved in the synthesis process and demands of modern drug development, majority of drug developers in this domain prefer to outsource their development and manufacturing operations to peptide therapeutics contract API manufacturers as a strategic solution to streamline their research and peptide synthesis efforts.

article thumbnail

BioSpace Movers & Shakers, Jan. 1

The Pharma Data

where he led global clinical development programs including clinical strategy, clinical development, and regulatory affairs. Reimer replaces Charlotte Russel and will be responsible for Alligator’s drug development candidates, with an emphasis on bringing mitazalimab and ATOR-1017 into Phase II efficacy studies.

article thumbnail

Molecular Diagnostic Tests: The Unsung Hero of Precise Clinical Decision Making

Roots Analysis

Molecular diagnostic solutions are pivotal across various medical fields, including oncological disorders, infectious diseases, genetic testing, and personalized medicine. Protein Based Assays- These tests measure the presence and levels of specific proteins, which can serve as biomarkers for various diseases.